Competing in Biotech
Margaux discusses the competitive landscape in biotech, highlighting how companies like Converge differentiate themselves by offering customizable solutions rather than full-service models. They aim to attract early customers who may not have extensive experience with machine learning, providing an accessible entry point. The conversation also touches on the unique appeal of IPO risk factors for those looking to unwind.In this clip
From this podcast
Equity
The AI industry's 'next big bet,' and should we just buy Chrome?
Related Questions